Related by context. Frequent words. (Click for all words.) 85 cutaneous T cell 69 metastatic renal cell carcinoma 69 hormone refractory prostate cancer 68 myelofibrosis 68 B CLL 67 refractory multiple myeloma 66 relapsing remitting multiple sclerosis 66 castration resistant prostate cancer 66 chronic lymphocytic leukemia CLL 66 metastatic colorectal cancer 66 unresectable 65 vandetanib 65 hepatocellular carcinoma HCC 64 chronic myeloid leukemia CML 64 ZYBRESTAT 64 NSCLC 64 nilotinib 64 CTCL 64 HRPC 63 metastatic melanoma 63 hematologic malignancies 63 renal cell carcinoma 63 chronic angina 63 lupus nephritis 63 mCRC 63 eltrombopag 63 TORISEL 63 hematological malignancies 63 HGS ETR1 63 myelodysplastic syndromes MDS 63 advanced NSCLC 62 pralatrexate 62 multiple myeloma 62 sapacitabine 62 BAY #-# 62 ADVEXIN 62 RG# [001] 62 AP# [003] 62 Torisel 61 hematological cancers 61 TREANDA 61 Clolar 61 solid tumors 61 Azixa 61 myelodysplastic syndromes 61 Phase 2b clinical 61 hypercalcemia 61 systemic lupus erythematosus 61 LymphoStat B 61 acute myeloid leukemia AML 61 eculizumab 61 resistant ovarian cancer 61 RRMS 61 systemic lupus erythematosus SLE 61 Taxotere R 60 FOLOTYN 60 hepatocellular carcinoma 60 neuroendocrine tumors 60 dasatinib 60 Nimotuzumab 60 talactoferrin 60 biologic therapy 60 INCB# [002] 60 IMGN# 60 liver metastases 59 evaluable 59 belinostat 59 Pixantrone 59 Phase 2a trial 59 Phase IIa clinical 59 CA4P 59 Phase 2a clinical 59 tamibarotene 59 chronic lymphocytic leukemia 59 T DM1 59 Cimzia ® 59 sunitinib 59 Cell Lung Cancer 59 Marketing Authorization Application MAA 59 tivozanib 59 Zerenex 59 myelodysplastic syndrome 59 vinorelbine 59 follicular lymphoma 59 azacitidine 59 Phase III Trial 59 L MTP PE 59 ofatumumab 59 investigational compound 58 Phase IIa trial 58 fingolimod 58 voreloxin 58 soft tissue sarcomas 58 monotherapy 58 follicular non 58 mixed dyslipidemia 58 Fast Track designation 58 Bevacizumab 58 blinatumomab 58 sBLA 58 ZEVALIN